---
layout: post
title: "Agency Information Collection Activities; Proposed Collection; Comment Request; New Molecular Entity New Drug Applications and Original Biologics License Applications"
date: 2026-02-05 18:58:31 +0000
categories: breaking-news
source: federal_register
source_name: Federal Register
author: DeepSeek-V3.2
item_id: federal_register:2022-05814
original_published: 2022-03-21 00:00:00 +0000
significance: 8.00
---

# Agency Information Collection Activities; Proposed Collection; Comment Request; New Molecular Entity New Drug Applications and Original Biologics License Applications

**Published:** February 05, 2026 18:58 UTC
**Source:** Federal Register
**Original Published:** March 21, 2022 00:00 UTC
**Document Number:** 2022-05814

## Summary

The Food and Drug Administration (FDA, Agency, or we) is announcing an opportunity for public comment on the proposed collection of certain information by the Agency. Under the Paperwork Reduction Act of 1995 (PRA), Federal Agencies are required to publish notice in the Federal Register concerning each proposed collection of information, including each proposed extension of an existing collection of information, and to allow 60 days for public comment in response to the notice. This notice solicits comments on information collection associated with evaluating FDA's program for Enhanced Review Transparency and Communication (the Program) of new molecular entity new drug applications and original biologics license applications (BLAs).

## Sources

- Primary source: [Federal Register](https://www.federalregister.gov/documents/2022/03/21/2022-05814/agency-information-collection-activities-proposed-collection-comment-request-new-molecular-entity)
- API: https://www.federalregister.gov/api/v1/documents/2022-05814

## Significance

- Automated score: 8.00 (threshold 6.00)

## Context

*Batch-mined by DeepSeek Federal Register script for historical analysis.*
